best digital currency to buy right now Top

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Reserve Bank of Australia: Potential inflation is still too high. There is still uncertainty about the prospects. The Committee is increasingly convinced that inflationary pressure is decreasing with the recent forecast, but the risk still exists. The Committee will continue to rely on data and changing risk assessments to guide its decision-making. Although the potential inflation is still at a high level, other recent economic activity data are mixed, but overall, November data is weaker than expected.Tang Hui, former member of the Standing Committee of Anshun Municipal Committee of Guizhou Province, was "double-opened", and the website of the State Supervision Committee of the Central Commission for Discipline Inspection was notified on December 10. According to the news of the Supervision Committee of Guizhou Provincial Commission for Discipline Inspection, with the approval of Guizhou Provincial Committee, the Supervision Committee of Guizhou Provincial Commission for Discipline Inspection filed a case review and investigation on Tang Hui, former member of the Standing Committee of Anshun Municipal Committee of Guizhou Province and former secretary of Xixiu District Committee.

South Korea's ruling party held final negotiations with the opposition party on the budget.Reserve Bank of Australia: It will take some time for inflation to continue to reach its target. The job market is still tight. The economic situation has affected the family's discretionary expenditure. The gap between total demand and supply continues to narrow, and output growth is weak.Goldman Sachs: It is expected that the output of OPEC+will still depend on the data, and it is assumed that the output of OPEC+will increase for four consecutive months from next July under the strong demand in summer. It is estimated that India's oil demand will increase by 300,000 barrels per day next year, accounting for nearly 30% of the global oil demand growth.

Malaysia exported 1.49 million tons of palm oil in November, down 15%.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Chaojie Co., Ltd.: In the field of humanoid robots, there are small batches of samples made of metal materials. Chaojie Co., Ltd. responded to investors' questions on the interactive platform, saying that the company already has PEEK auto parts for customers. At present, in the field of humanoid robots, the company has supplied customers with small batches of metal samples. Because humanoid robots have not yet reached the stage of industrial scale, they have not yet obtained batch orders. At present, this business accounts for a relatively low proportion of the company's revenue, which has not had a significant impact on the company's performance.